BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22212939)

  • 1. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
    Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
    Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.
    Mita K; Kim SR; Kudo M; Imoto S; Nakajima T; Ando K; Fukuda K; Matsuoka T; Maekawa Y; Hayashi Y
    World J Gastroenterol; 2010 Sep; 16(33):4187-92. PubMed ID: 20806437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
    Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
    J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
    Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
    PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.
    Guo D; Wan W; Bai X; Wen R; Peng J; Lin P; Liao W; Huang W; Liu D; Peng Y; Kang T; Yang H; He Y
    Abdom Radiol (NY); 2024 May; 49(5):1432-1443. PubMed ID: 38584190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonazoid-enhanced ultrasound images of multiacinar cirrhotic nodules showing a "donut-like" hyperintense appearance on Gd-EOB-MRI: a case report.
    Kubota R; Toshikuni N; Tsutsumi M; Tsuchishima M
    J Med Ultrason (2001); 2023 Oct; 50(4):573-574. PubMed ID: 37555876
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.
    Li J; Ye X; Wang J; Yuan G; He S
    Medicine (Baltimore); 2022 Sep; 101(36):e30482. PubMed ID: 36086711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
    Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
    World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Comparison of Prediction Models Based on Sonovue- and Sonazoid-Enhanced Ultrasound for Pathologic Grade and Microvascular Invasion in Hepatocellular Carcinoma.
    Zhang R; Li D; Chen Y; Xu W; Zhou W; Lin M; Xie X; Xu M
    Ultrasound Med Biol; 2024 Mar; 50(3):414-424. PubMed ID: 38155069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma.
    Yan Y; Lin XS; Ming WZ; Chuan ZQ; Hui G; Juan SY; Shuang W; Yang Fan LV; Dong Z
    Acad Radiol; 2024 Mar; 31(3):859-869. PubMed ID: 37689559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic values of contrast-enhanced MRI and contrast-enhanced CT for evaluating the response of hepatocellular carcinoma after transarterial chemoembolisation: a meta-analysis.
    Zhang C; Chen X; Wang J; Luo T
    BMJ Open; 2024 Apr; 14(4):e070364. PubMed ID: 38580362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell hepatocellular carcinoma: Gd-EOB-DTPA-enhanced MR imaging features and prognosis.
    Song M; Tao Y; He K; Du M; Guo L; Hu C; Zhang W
    Abdom Radiol (NY); 2024 Apr; ():. PubMed ID: 38557768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review.
    Jeong WK
    J Liver Cancer; 2023 Sep; 23(2):272-283. PubMed ID: 37723641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.
    Kumar A; Acharya SK; Singh SP; Saraswat VA; Arora A; Duseja A; Goenka MK; Jain D; Kar P; Kumar M; Kumaran V; Mohandas KM; Panda D; Paul SB; Ramachandran J; Ramesh H; Rao PN; Shah SR; Sharma H; Thandassery RB;
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S3-S26. PubMed ID: 25755608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
    Chen Y; Zhu W; Yi Y; Cao H; Chen F; Zhu Q
    Med Ultrason; 2024 Feb; ():. PubMed ID: 38537180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.
    Kim DH; Yoon JH; Choi MH; Lee CH; Kang TW; Kim HA; Ku YM; Lee JM; Kim SH; Kim KA; Lee SL; Choi JI
    J Hepatol; 2024 Apr; ():. PubMed ID: 38636849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings.
    Lee SW; Kang MK; Zhang X
    J Liver Cancer; 2023 Sep; 23(2):238-240. PubMed ID: 37726895
    [No Abstract]   [Full Text] [Related]  

  • 18. Models of hepatocellular carcinoma and biomarker strategy.
    Bagi CM; Andresen CJ
    Cancers (Basel); 2010 Jul; 2(3):1441-52. PubMed ID: 24281167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of HCC diagnosis in the KLCA-NCC guidelines: a closer look at MRI contrast agents and HCC imaging hallmarks.
    Min JH; Kim YK
    J Liver Cancer; 2024 Mar; 24(1):7-8. PubMed ID: 37927042
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.